Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection

被引：0
|
作者：
Benjamin Petsch
Margit Schnee
Annette B Vogel
Elke Lange
Bernd Hoffmann
Daniel Voss
Thomas Schlake
Andreas Thess
Karl-Josef Kallen
Lothar Stitz
Thomas Kramps
机构：
[1] Institute of Immunology,
[2] Friedrich-Loeffler-Institut,undefined
[3] CureVac GmbH,undefined
[4] Department of Experimental Animal Facilities and Biorisk Management,undefined
[5] Institute of Diagnostic Virology,undefined
[6] Friedrich-Loeffler-Institut,undefined
[7] Current addresses: CureVac GmbH,undefined
[8] Tübingen,undefined
[9] Germany (B.P.); Institute of Immunology,undefined
[10] Friedrich-Loeffler-Institut,undefined
[11] Greifswald-Insel Riems,undefined
[12] Germany (A.B.V. and L.S.).,undefined
来源：
Nature Biotechnology | 2012年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Petsch et al. apply mRNA vaccination for the first time to infectious disease, demonstrating immunogenicity and/or protective effects against influenza virus in mice, ferrets and pigs.
引用
收藏
页码：1210 / 1216
页数：6
相关论文
共 50 条
  • [21] Protective efficacy of neutralizing antibodies against Ebola virus infection
    Takada, Ayato
    Ebihara, Hideki
    Jones, Sueven
    Feldmann, Heinz
    Kawaoka, Yoshihiro
    VACCINE, 2007, 25 (06) : 993 - 999
  • [22] Protective Role of Combined Polyphenols and Micronutrients against Influenza A Virus and SARS-CoV-2 Infection In Vitro
    De Angelis, Marta
    Della-Morte, David
    Buttinelli, Gabriele
    Di Martino, Angela
    Pacifici, Francesca
    Checconi, Paola
    Ambrosio, Luigina
    Stefanelli, Paola
    Palamara, Anna Teresa
    Garaci, Enrico
    Ricordi, Camillo
    Nencioni, Lucia
    BIOMEDICINES, 2021, 9 (11)
  • [23] Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses
    Martin, Veronica
    Pascual, Elena
    Avia, Miguel
    Pena, Lourdes
    Valcarcel, Felix
    Sevilla, Noemi
    PLOS ONE, 2015, 10 (11):
  • [24] Vaccines and therapeutics against influenza virus infections
    Saito, T
    Tashiro, M
    PEDIATRICS INTERNATIONAL, 2000, 42 (02) : 219 - 225
  • [25] Immune Response and Protective Efficacy of Inactivated and Live Influenza Vaccines Against Homologous and Heterosubtypic Challenge
    E. Y. Boravleva
    A. V. Lunitsin
    A. P. Kaplun
    N. V. Bykova
    I. V. Krasilnikov
    A. S. Gambaryan
    Biochemistry (Moscow), 2020, 85 : 553 - 566
  • [26] DEVELOPMENT OF VACCINES AGAINST INFLUENZA IN CONNECTION WITH THE EPIDEMIOLOGY OF INFLUENZA INFECTION
    BELYAKOV, VD
    ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII, 1984, (03): : 115 - 119
  • [27] Immune Response and Protective Efficacy of Inactivated and Live Influenza Vaccines Against Homologous and Heterosubtypic Challenge
    Boravleva, E. Y.
    Lunitsin, A. V.
    Kaplun, A. P.
    Bykova, N. V.
    Krasilnikov, I. V.
    Gambaryan, A. S.
    BIOCHEMISTRY-MOSCOW, 2020, 85 (05) : 553 - 566
  • [28] PROTECTIVE EFFICACY OF COMBINED LIVE INTRANASAL AND INACTIVATED INFLUENZA-A VIRUS-VACCINES IN THE ELDERLY
    TREANOR, JJ
    MATTISON, HR
    DUMYATI, G
    YINNON, A
    ERB, S
    OBRIEN, D
    DOLIN, R
    BETTS, RF
    ANNALS OF INTERNAL MEDICINE, 1992, 117 (08) : 625 - 633
  • [29] Mechanism of protective immunity against influenza virus infection in mice without antibodies
    Epstein, SL
    Lo, CY
    Misplon, JA
    Bennink, JR
    JOURNAL OF IMMUNOLOGY, 1998, 160 (01): : 322 - 327
  • [30] Protective Effect of Flavonoids from Ohwia caudata against Influenza a Virus Infection
    Bin Kwon, Eun
    Yang, Hye Jin
    Choi, Jang-Gi
    Li, Wei
    MOLECULES, 2020, 25 (19):
12345